Market Value2,923,924,032
Total Holdings55
File Date2025-08-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
KNSA / Kiniksa Pharmaceuticals International, plc
DAWN / Day One Biopharmaceuticals, Inc.
XNCR / Xencor, Inc.
BBNX / Beta Bionics, Inc.
DYN / Dyne Therapeutics, Inc.
APGE / Apogee Therapeutics, Inc.
NUVL / Nuvalent, Inc.
HROW / Harrow, Inc.
INSP / Inspire Medical Systems, Inc.
CAI / Caris Life Sciences, Inc.
NBIX / Neurocrine Biosciences, Inc.
MRVI / Maravai LifeSciences Holdings, Inc.
SYRE / Spyre Therapeutics, Inc.
ISRG / Intuitive Surgical, Inc.
VKTX / Viking Therapeutics, Inc.
KIDS / OrthoPediatrics Corp.
IRTC / iRhythm Holdings, Inc.
US252131AK39 / CONV. NOTE
ADPT / Adaptive Biotechnologies Corporation
CSTL / Castle Biosciences, Inc.
SION / Sionna Therapeutics, Inc.
US46333XAH17 / CONV. NOTE
US64049MAB63 / NeoGenomics Inc
NVCR / NovoCure Limited
CELC / Celcuity Inc.
ARGX / argenx SE - Depositary Receipt (Common Stock)
DNTH / Dianthus Therapeutics, Inc.
GKOS / Glaukos Corporation
GH / Guardant Health, Inc.
TMDX / TransMedics Group, Inc.
SRZN / Surrozen, Inc.
SRPT / Sarepta Therapeutics, Inc.
KRYS / Krystal Biotech, Inc.
CGON / CG Oncology, Inc.
CGEM / Cullinan Therapeutics, Inc.
GMED / Globus Medical, Inc.
PEN / Penumbra, Inc.
APLS / Apellis Pharmaceuticals, Inc.
BCAX / Bicara Therapeutics Inc.
IRWD / Ironwood Pharmaceuticals, Inc.
ASND / Ascendis Pharma A/S
TRVI / Trevi Therapeutics, Inc.
AARD / Aardvark Therapeutics, Inc.
MTSR / Metsera, Inc.
GUARDANT HEALTH INC / DEBT 1.250% 2/1 (40131MAD1)
IMMUNOCORE HLDGS PLC / NOTE 2.500% 2/0 (45258DAB1)
IRHYTHM TECHNOLOGIES INC / NOTE 1.500% 9/0 (450056AB2)
KARYOPHARM THERAPEUTICS INC / NOTE 6.000% 5/1 (48576UAD8)
REPLIGEN CORP / NOTE 1.000%12/1 (759916AD1)
US02081GAB86 / Alphatec Holdings, Inc.
TMO / Thermo Fisher Scientific Inc.
SKYE / Skye Bioscience, Inc.
UNH / UnitedHealth Group Incorporated
RGEN / Repligen Corporation
REPL / Replimune Group, Inc.
XENE / Xenon Pharmaceuticals Inc.
LUNG / Pulmonx Corporation
ZURA / Zura Bio Limited
EWTX / Edgewise Therapeutics, Inc.
MDGL / Madrigal Pharmaceuticals, Inc.
ALGN / Align Technology, Inc.
DHR / Danaher Corporation
BPMC / Blueprint Medicines Corporation
AVTE / Aerovate Therapeutics, Inc.
CBIO / Crescent Biopharma, Inc.
ORKA / Oruka Therapeutics, Inc.
LEGN / Legend Biotech Corporation - Depositary Receipt (Common Stock)
ATEC / Alphatec Holdings, Inc.